[Capsular polysaccharide antibodies after pneumococcal polysaccharide vaccination in patients with chronic respiratory disease].

@article{Saito2005CapsularPA,
  title={[Capsular polysaccharide antibodies after pneumococcal polysaccharide vaccination in patients with chronic respiratory disease].},
  author={Wakana Saito and Hideaki Nagai and Junko Suzuki and Kimihiko Masuda and Atsuhisa Tamura and Naohiro Nagayama and Shinobu Akagawa and Yoshiko Kawabe and Kazuko Machida and Atsuyuki Kurashima and Hideki Yotsumoto and Tsuyoshi Saito and Tomo Arai and Nobuhiko Okabe},
  journal={Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society},
  year={2005},
  volume={43 5},
  pages={277-82}
}
We investigated the antibody response to a 23-valent pneumococcal polysaccharide vaccine (23PSV), in 151 patients (average age: 70 years old) with chronic respiratory disease. Serotype-specific IgG antibodies to 4 pneumococcal capsular polysaccharides (6B, 14, 19F, and 23F) were analyzed by ELISA before, and one month after, 23PSV vaccination in all patients. Patients showed a significant increase in specific IgG levels to Streptococcus pneumoniae after 23PSV vaccination (5.5 times-20.9 times… CONTINUE READING